Physician

James Thomas Sandwich, M.D.

According to 2025 Medicare claims, James Sandwich, M.D. (NPI: 1699779199) practices internal medicine in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from Pike, GA. This provider's primary affiliated billing organization is JAMES T. SANDWICH, M.D., P.C. (NPI: 1073624763; TIN: 582301495) and primary practice location at 30224-4818.

Sandwich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,678 traditional Medicare patients, billed 13,635 HCPCS/CPT codes, and received $966,530 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 361 prescription claims across 198 beneficiaries totaling $114,225 in drug costs, led by Otezla (Apremilast). 2023 DME data shows 69 claims. Open Payments data shows 48 records totaling $739. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $576,842 to $966,530. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $150,096 and ending at $114,225. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,847	14,425	$576,842
2016	1,504	11,912	$461,912
2017	1,649	12,813	$505,045
2018	1,585	12,203	$549,263
2019	877	6,499	$333,746
2020	1,196	9,044	$491,833
2021	1,522	11,992	$625,286
2022	1,639	13,428	$641,300
2023	1,748	13,810	$783,393
2024	1,678	13,635	$966,530

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	252	541	$150,096
2016	359	841	$450,872
2017	316	746	$453,344
2018	158	313	$204,973
2019	259	658	$338,646
2020	342	854	$518,759
2021	432	1,119	$872,485
2022	383	898	$830,383
2023	248	534	$529,488
2024	198	361	$114,225

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	26	38	$8,452
2022	37	47	$10,538
2023	55	69	$14,648
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	606	781	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,262	2,008	$58
17000	Destruction of precancer skin growth, 1 growth	969	1,492	$39
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	393	519	$38
17003	Destruction of precancer skin growth, 2-14 growths	760	4,708	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Otezla	Apremilast	14	420	$67,328
Doxycycline Hyclate	Doxycycline Hyclate	121	1,556	$1,234
Clobetasol Propionate	Clobetasol Propionate	15	420	$565
Ketoconazole	Ketoconazole	29	763	$417
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	149	$125

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	48	$739	Organogenesis Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Thomas Sandwich, M.D.?

Tedicare shows public-source Medicare data for James Thomas Sandwich, M.D. (NPI 1699779199), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Thomas Sandwich, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Thomas Sandwich, M.D.?

James Thomas Sandwich, M.D. is linked to JAMES T. SANDWICH, M.D., P.C. (billing NPI 1073624763) in the available physician profile data.

Does James Thomas Sandwich, M.D. have Open Payments data?

James Thomas Sandwich, M.D. has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.